Clovis Oncology, Inc.
CLVSQ
OTC PK
09/30/2022 | 06/30/2022 | ||||
---|---|---|---|---|---|
Revenue | -4.60% | -6.14% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -4.60% | -6.14% | |||
Cost of Revenue | -7.71% | -2.45% | |||
Gross Profit | -3.60% | -7.28% | |||
SG&A Expenses | -6.78% | 11.56% | |||
Depreciation & Amortization | 0.00% | 0.00% | |||
Other Operating Expenses | -61.46% | 256.38% | |||
Total Operating Expenses | -18.17% | 8.18% | |||
Operating Income | 25.51% | -17.92% | |||
Income Before Tax | 21.57% | -18.38% | |||
Income Tax Expenses | 185.37% | 65.83% | |||
Earnings from Continuing Operations | 21.47% | -18.55% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 21.47% | -18.55% | |||
EBIT | 25.51% | -17.92% | |||
EBITDA | 26.32% | -18.67% | |||
EPS Basic | 21.79% | -13.73% | |||
Normalized Basic EPS | 21.89% | -13.61% | |||
EPS Diluted | 21.79% | -13.73% | |||
Normalized Diluted EPS | 21.89% | -13.61% | |||
Average Basic Shares Outstanding | 0.41% | 4.22% | |||
Average Diluted Shares Outstanding | 0.41% | 4.22% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |